hypophosphataemia treatment height gain nephrocalcinosis clinical data patients hypophosphataemia height data SD difference final height patients vitamin phosphate years hypophosphataemic family members mean final SD score treated patients value treatment average absolute gain cm expected height values treated patients detectable nephrocalcinosis normal renal function daily phosphate intake excretion patients nephrocalcinosis patients normal renal morphology difference doses vitamin groups average urinary calcium creatinine ratio groups similar hypercalciuric mmol mmol limit group nephrocalcinosis incidence hypercalciuric episodes group nephrocalcinosis observations observations benefits risks treatment patients hypophosphataemia high dose phosphate important factor development nephrocalcinosis group patients 